# KALVISTA PHARMACEUTICALS INC (KALV)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/KALV/

- Reporting holders: 1
- Reported value: $189
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [IFP Advisors, Inc](https://holderbook.com/funds/1641866-ifp-advisors-inc/) | $189 | 7 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 1 | $189 |
| Q1 2026 | 186 | $1.5B |
| Q4 2025 | 161 | $1.1B |
| Q3 2025 | 147 | $739.0M |
| Q2 2025 | 141 | $629.7M |
| Q1 2025 | 133 | $649.6M |
| Q4 2024 | 129 | $470.0M |
| Q3 2024 | 121 | $569.4M |
| Q2 2024 | 119 | $569.8M |
| Q1 2024 | 129 | $577.0M |
| Q4 2023 | 98 | $492.0M |
| Q3 2023 | 102 | $364.7M |